BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1811286)

  • 1. Gastric juice and analysis of basal and stimulated secretion following treatment with rice-bran oil.
    Lloris JM; Bolant B; Gimeno L; Cejalvo D; Gimeno LO; Calvo MA; Perkins I
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):245-8. PubMed ID: 1811286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiulcerogenic properties of bran rice oil in rats].
    Gimeno Forner L; Bolant Hernández B; Calvo Bermúdez MA; Ariño Matíez J; Palomar Pérez EF; Amorós Escolar JC; Lloris Carsí JM; Narbona B
    Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):225-30. PubMed ID: 2734466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gastric antisecretory activity of a phenothiazine molecule, LM 24056.
    Vatier J; Bessac JF; Bonfils S
    Arzneimittelforschung; 1982; 32(8):815-9. PubMed ID: 6814453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of esaprazole activity on basal gastric secretion and on pentagastrin-stimulated secretion in healthy volunteers.
    Erembourg L; Reggiani P; Tosi GP; Ferla G; Beinat L
    Int J Clin Pharmacol Res; 1987; 7(2):95-100. PubMed ID: 3583500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
    Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
    Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranitidine inhibits gastric acid and pepsin secretion following sham feeding.
    Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL
    Hepatogastroenterology; 1980 Oct; 27(5):377-80. PubMed ID: 6110626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretagogue-specific effects of interleukin-1 on gastric acid secretion.
    Wallace JL; Cucala M; Mugridge K; Parente L
    Am J Physiol; 1991 Oct; 261(4 Pt 1):G559-64. PubMed ID: 1681735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of pepsinogen secretion: influence of pentagastrin on pepsinogen secretion in man.
    Ten Kate RW; Tuynman HA; Festen HP; Pals G; Meuwissen SG
    Hepatogastroenterology; 1990 Feb; 37(1):124-7. PubMed ID: 2107135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thyroid hormones on basal and stimulated gastric acid secretion due to histamine, carbachol and pentagastrin in rats.
    Rafsanjani FN; Z Asl S; Naseri MK; Vahedian J
    Saudi Med J; 2003 Apr; 24(4):341-6. PubMed ID: 12754530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta3 inhibits pentagastrin-stimulated gastric acid secretion in rats.
    Beckert S; Wolf SC; Farrahi F; Zittel TT; Coerper S
    Med Sci Monit; 2005 Mar; 11(3):BR80-3. PubMed ID: 15735558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of metiamide, a histamine H2-receptor antagonist on reserpine-induced gastric ulcers and acid secretion.
    Hano J; Bugajski J; Wantuch C
    Pol J Pharmacol Pharm; 1983; 35(1):15-27. PubMed ID: 6412220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological stimulation of pepsin secretion. The role of vagal innervation.
    Guldvog I; Berstad A
    Scand J Gastroenterol; 1981; 16(1):17-25. PubMed ID: 6785873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086).
    Barzaghi F; Cesana R; Delevallée F; Fournex R; Nencioni A; Vincent JC; Deraedt R
    Arzneimittelforschung; 1985; 35(9):1412-6. PubMed ID: 4084342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization within and between secretagogues of canine gastric acid and pepsin secretion.
    Hirschowitz BI
    J Pharmacol Exp Ther; 1986 Jan; 236(1):14-23. PubMed ID: 2867211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin effects on gastric electrolytes and pepsin in dogs with various secretory stimuli.
    Hirschowitz BI
    J Pharmacol Exp Ther; 1987 Nov; 243(2):501-6. PubMed ID: 2890756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of impromidine and pentagastrin on gastric output of histamine, acid and pepsin in man.
    Peden NR; Boyd EJ; Callachan H; Shepherd DM; Wormsley KG
    Hepatogastroenterology; 1982 Feb; 29(1):30-4. PubMed ID: 6212525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights in the mechanisms underlying the anti-ulcer activity of nicorandil.
    Ismail HA; Khalifa MM; Hassan MK; Ashour OM
    Pharmazie; 2007 Jan; 62(1):60-6. PubMed ID: 17294816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of gastric acidity in the ovine fetus.
    Shulkes A; Chick P; Hardy KJ; Robinson P; Trahair J
    J Dev Physiol; 1985 Jun; 7(3):195-206. PubMed ID: 2861225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer.
    Hirschowitz BI
    Gastroenterology; 1984 May; 86(5 Pt 1):843-51. PubMed ID: 6423436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.